Skip to main content
Fig. 2 | Future Journal of Pharmaceutical Sciences

Fig. 2

From: Evaluation of cardiopreventive effects of Ximenia americana (Linn.) and Pappea capensis (Eckl. and Zeyh.) leaf aqueous extracts in rat models with myocardial infarction

Fig. 2

shows LC–MS chromatogram for aqueous leaf extracts of Pappea capensis. The peaks represent phytocompounds with different retention times. The identities phytocompounds were proposed based on their general fragmentation pattern and using reference spectra published by the library–MS databases of the National Institute of Standards and Technology (NIST). Twenty-four phytocompounds were successfully identified, including flavonoids (hesperidin, quercitrin, epicatechin, myricetin, quercetin-3 glucoside, rhamnetin, kaempferol-3-0-arabinopyranoside, quercetin-3-O-beta-arabinopyranosyl, quercetin-3-O-beta-D-L-glucosyl, quercetin-3-O-beta-D-L-glucoside and quercetin-3-O-beta-D-G-glucoside), glycosides (quercetin rhamnoside, kaempferol hexoside and quercetin-3-0-alpha-L-rhamnoside), and phenolic acids (protocatechuic acid, gallic acid, caffeic acid, p-coumaric acid, ferulic acid, 3,4,5,trimethoxycinnamic acid, ellagic acid, chlorogenic acid, gentisic acid and isoferulic acid)

Back to article page